Researchers at the University of Minnesota found a three-way link among antibiotic use in infants, changes in the gut bacteria, and disease later in life.
The imbalances in gut microbes, called dysbiosis, have been tied to infectious diseases, allergies and other autoimmune disorders, and even obesity, later in life.
The study, led by Biomedical Informatics and Computational Biology programme graduate student fellow Pajau Vangay, also developed a predictive model with potential clinical importance for measuring healthy development of bacteria in the gut of young children.
Other studies have shown profound short- and long-term effects of antibiotics on the diversity and composition of the bacteria in our bodies, called our microbiome.
"Diseases related to metabolism and the immune system are increasing dramatically, and in many cases we don't know why," said the study's senior author Dan Knights, a computational biologist and assistant professor in the University of Minnesota's Department of Computer Science and Engineering and Biotechnology Institute.
"Over the past year we synthesised hundreds of studies and found evidence of strong correlations between antibiotic use, changes in gut bacteria, and disease in adulthood," Knights said.
Knights and his colleagues developed a framework to map how antibiotics may be acting in the gut to cause disease later in life.
In the case of allergies, for example, the use of antibiotics may eradicate key gut bacteria that help immune cells mature.
These cells would have been essential for keeping the immune system at bay when confronted with allergens. Even if these bacteria return, the immune system remains impaired.
The study also examined the development of bacteria in the gut. Researchers demonstrated that an infant's age could be predicted within 1.3 months based on the maturity of their gut bacteria.
This finding could lead to a clinical test and interventions for children whose microbiome is developmentally delayed due to antibiotics or other factors, researchers said.
The findings are published in the journal Cell Host & Microbe.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
